IL33 and metabolic dysfunction-associated steatohepatitis: Although IL-33 induction in the liver can serve to combat HBV infection80, it is also elevated in other liver pathologies, including nonalcoholic steatohepatitis and intrahepatic cholangiocarcinoma81–83.